HELDER GARCIA: Open Payments
NPI 1447424973 · PUTNAM, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$871 in 37 payments from 16 companies in 2025. Trend: 2023 $128 · 2024 $110 · 2025 $871
Food & beverage: $871
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $168 |
| Novo Nordisk Inc | 5 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $103 |
| ABBVIE INC. | 3 | $78 |
| Amgen Inc. | 2 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Ardelyx, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $38 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $28 |
Products named: Wegovy, Kerendia, FARXIGA, JARDIANCE, QULIPTA, IBSRELA, The Cologuard Plus Collection Kit, REPATHA.
Industry payments across CT — which companies pay providers there.
